Complete guide to GCC hospital research and innovation — clinical trials management, IRB/ethics, translational research, DHA research standards, Saudi research strategy, and research management software.
GCC conducts 2,000+ clinical trials. Saudi Vision 2030 targets $1B+ in health research. IRB/REC is mandatory. This guide covers GCC hospital research and innovation.
Research Infrastructure
| Component | Description | Requirement |
|---|---|---|
| IRB/REC | Research ethics review board | Mandatory (SFDA, DHA) |
| Research office | Research administration and support | Recommended |
| CTU (Clinical Trials Unit) | Trial coordination and management | For trial centres |
| Data management | Trial data collection and management | 21 CFR Part 11 compliant |
| Pharmacy/study drug | Study drug storage and dispensing | GCP compliant |
| Lab/research lab | Research laboratory facilities | GLP compliant |
| Research training | GCP training for all research staff | Mandatory |
Clinical Trial Process
- Protocol development: Develop research protocol with objectives, methodology, statistics
- IRB/REC submission: Submit protocol, consent forms, investigator credentials
- SFDA/DHA approval: Get regulatory approval (SFDA for Saudi, DHA for Dubai)
- Patient recruitment: Recruit eligible patients with informed consent
- Trial conduct: Conduct trial per protocol with GCP compliance
- Data collection: Collect and manage trial data in EDC system
- Monitoring: Regular monitoring visits by sponsor/CRO
- Analysis: Statistical analysis of trial data
- Publication: Publish results in peer-reviewed journals
Innovation Areas in GCC Healthcare
- AI in healthcare: AI scribe, AI CDS, AI imaging — Saudi and UAE leading
- Genomics: Saudi Human Genome Programme — genetic disease research
- Telemedicine: Virtual care, remote monitoring, AI triage
- 3D printing: Patient-specific implants, surgical models
- Robotics: Surgical robots, pharmacy robots, rehabilitation robots
- Digital therapeutics: Software as treatment for diseases
- Regenerative medicine: Stem cell therapy, tissue engineering
Frequently Asked Questions
- How many clinical trials are conducted in the GCC?
- GCC conducts 2,000+ clinical trials: Saudi Arabia — 1,000+, UAE — 500+, Qatar — 200+, Kuwait — 100+, Bahrain — 100+, Oman — 100+. Most trials are in oncology, cardiology, and diabetes. Saudi FDA (SFDA) regulates clinical trials. DHA regulates trials in Dubai. Most GCC trials are international multi-centre trials.
- What is IRB and is it required in the GCC?
- IRB (Institutional Review Board) or Research Ethics Committee (REC) is required for all clinical research in the GCC. IRB reviews: research protocol, informed consent, patient safety, data protection, and risk-benefit ratio. SFDA (Saudi) requires IRB approval for all clinical trials. DHA requires IRB/REC approval for all research in Dubai facilities.
- What is Saudi Vision 2030 research strategy?
- Saudi Vision 2030 research strategy: 1) Establish National Research Institute, 2) Fund $1B+ in health research, 3) Build clinical trial infrastructure, 4) Develop Saudi researchers, 5) International research partnerships, 6. Focus areas: diabetes, cancer, genetic diseases, AI in healthcare. Target: top 20 globally in research by 2030.